Faculty profile

Maya Shmulevitz

ResearcherMedical Microbiology and ImmunologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.

Maya Shmulevitz

Researcher

Medical Microbiology and Immunology

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 10 research grants (9 CIHR, 1 NSERC), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Virus Replication Binding Dissemination Infection Mutations Sialic Acid Therapeutic

Latest papers

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model.
Journal of virology · 2026
Enhanced sialic acid engagement at physiological temperatures by reovirus σ1 mutants facilitates infection of breast cancer cells with low levels of high-affinity receptors.
Journal of virology · 2026 · senior author
Spatiotemporal coordination of reovirus peripheral core replication to perinuclear whole virus assembly.
PLoS pathogens · 2025 · senior author

All 27 publications

Latest funding

Molecular Determinants of Virus-Sialic Acid Binding and its Role in Infection and Dissemination at distinct niches
CIHR · 2025 · Nominated PI
$1,357,876
Understanding why some breast cancers resist reovirus oncolysis and expanding reovirus as a cancer therapy towards resistant breast cancers
CIHR · 2024 · Nominated PI
$65,000
Using apathogenic and mammalian-ubiquitous reoviruses to safely discover genetic and phenotypic changes in viruses that promote adaptation to new host species and distinct niches within a host.
NSERC · 2022 · Principal investigator
$102,000

All 10 grants and awards

27 publications.

A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model.

Ao Z, Vendramelli R, Buyu M, Truong T, Liu D, Gao N, Ma H, Amos S, Lawrynuik P, Nyamekye M, Fowke KR, Pelka P, Shmulevitz M, Kung SKP, Kobasa D, Yao X

Journal of virology2026

DOI: 10.1128/jvi.00097-26 PMID: 42300735

Enhanced sialic acid engagement at physiological temperatures by reovirus σ1 mutants facilitates infection of breast cancer cells with low levels of high-affinity receptors.

Taal D, Luong S, Walker M, Eaton HE, Brown PI, Footz T, Shmulevitz M

Journal of virology2026Senior author

DOI: 10.1128/jvi.00074-26 PMID: 41817273

Spatiotemporal coordination of reovirus peripheral core replication to perinuclear whole virus assembly.

Kniert J, Terino D, Eaton HE, Lin QF, Wu SY, Strickfaden H, Shmulevitz M

PLoS pathogens2025Senior author

DOI: 10.1371/journal.ppat.1013238 PMID: 40892861

Mathematical modelling of reoviruses in cancer cell cultures.

Baabdulla AA, Cristi F, Shmulevitz M, Hillen T

PloS one2025

DOI: 10.1371/journal.pone.0318078 PMID: 40294035

Rational design of an artificial tethered enzyme for non-templated post-transcriptional mRNA polyadenylation by the second generation of the C3P3 system.

Le Boulch M, Jacquet E, Nhiri N, Shmulevitz M, Jaïs PH

Scientific reports2024

DOI: 10.1038/s41598-024-55947-0 PMID: 38431749

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment.

Cristi F, Walters M, Narayan N, Agopsowicz K, Hitt MM, Shmulevitz M

Molecular therapy oncolytics2023Senior author

DOI: 10.1016/j.omto.2023.100743 PMID: 38033400

Reovirus genomic diversity confers plasticity for protease utility during adaptation to intracellular uncoating.

Lin QF, Wong CXL, Eaton HE, Pang X, Shmulevitz M

Journal of virology2023Senior author

DOI: 10.1128/jvi.00828-23 PMID: 37747236

Special Issue of the 4th Symposium of the Canadian Society for Virology 2022.

Meier-Stephenson V, Evans D, Hobman T, Marchant D, Noyce R, Shmulevitz M

Viruses2023Senior author

DOI: 10.3390/v15071512 PMID: 37515198

p38 Mitogen-Activated Protein Kinase Signaling Enhances Reovirus Replication by Facilitating Efficient Virus Entry, Capsid Uncoating, and Postuncoating Steps.

Mohamed A, Lin QF, Eaton HE, Shmulevitz M

Journal of virology2023Senior author

DOI: 10.1128/jvi.00009-23 PMID: 36744961

Reovirus uses temporospatial compartmentalization to orchestrate core versus outercapsid assembly.

Kniert J, Dos Santos T, Eaton HE, Jung Cho W, Plummer G, Shmulevitz M

PLoS pathogens2022Senior author

DOI: 10.1371/journal.ppat.1010641 PMID: 36099325